Filing Flows

Filing Flows › Ginkgo Bioworks Holdings (DNA) › Next earnings date

Ginkgo Bioworks Holdings (DNA) earnings: beat the estimate

Ginkgo Bioworks Holdings (DNA) reported on Nov 5, 2026 and beat the EPS estimate: −$0.48 against −$0.54 (+10.4%). It beat the EPS estimate in 40% of the quarters on record.

Last result+10.4% vs estimate
Beat rate40%

The last report

Ginkgo Bioworks Holdings reported revenue of $20.2M for the second quarter 2026 (-48% Y/Y), net loss $46.7M. How it makes money → · Every quarter →

Ginkgo Bioworks Holdings: EPS against the estimate, last 5 reportsGinkgo Bioworks Holdings: EPS against the estimate, last 5 reportsEstimateReported−$1.24−$1.45Nov 25−$1.11−$0.77Feb 26−$1.34−$1.39May 26−$0.70−$0.73Aug 26−$0.54−$0.48Nov 26
Latest (Nov 26): Estimate −$0.54, Reported −$0.48.

Ginkgo Bioworks Holdings' latest quarter

Ginkgo Bioworks Holdings, Q2 2026: revenue $20.2M (-48% year over year), operating margin -290.5%, net loss $46.7M, operating cash flow −$44.3M. The chart follows the revenue to costs, profit and cash.

Questions

Did Ginkgo Bioworks Holdings beat earnings?

Ginkgo Bioworks Holdings (DNA) reported on Nov 5, 2026 and beat the EPS estimate: −$0.48 against −$0.54 (+10.4%).

When does DNA report earnings?

The next date is not set yet.

Does Ginkgo Bioworks Holdings usually beat earnings?

It beat the consensus EPS estimate in 40% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.